An observational study in Coronary Artery Calcification, Intravascular Lithotripsy and Excimer Laser-coronary Atherectomy, sponsored by Medical University of Silesia. Completed at 20 sites in 2 countries. Per ClinicalTrials.gov, last updated 2024-02-23.
Sponsored by Medical University of Silesia · Observational
The IVL- ELCA DRAGON Registry is a multicenter study that enrolled consecutive patients with stent underexpansion treated with IVL ora ELCA in high-volume PCI centers.
The primary efficacy endpoint was device success (technical success with a final stent expansion ≥ 80%). Thirty days device-oriented composite endpoint (DOCE: cardiac death, target lesion revascularization, or target vessel myocardial infarction) was the secondary endpoint.
182 studies on the registry are indexed under Calcinosis; 33 are open to participants now.
This study's enrollment of 121 is below the median of 172 across 70 observational studies indexed under Calcinosis.
Browse Calcinosis studies →Medical University of Silesia is the lead sponsor of 111 studies on the registry; 24 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with underexpanded coronary stent were included regardless of time since stent implantation. Patients who did not undergo intravasuclar imaging during PCI were excluded.
Stent underexpansion as stent expansion of \<80% assessed with intravascular imaging (minimum in-stent lumen area divided by average reference lumen area x100%).
Device: Stent Underexpansion
Device: Stent Underexpansion
Stent underexpansion was diagnosed as stent expansion of \<80% assessed with intravascular imaging.
The primary efficacy endpoint was device success
Technical success with a final stent expansion ≥80%.
Time frame: During procedure
Device-oriented composite endpoint (DOCE)
cardiac death, target lesion revascularization, or target vessel myocardial infarction
Time frame: Thirty days
Plan to share: Undecided
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Silesia